Sky-high for charity
Fasha Mahjoor, Founder and CEO of Phenomenex (Torrance, California, USA), will leap off the 87th floor of The Shard in London on 3 September to raise money for The Outward Bound Trust, an educational charity.
Fasha Mahjoor — Founder and CEO of Phenomenex (Torrance, California, USA) — will leap off the 87th floor of The Shard in London on 3 September to raise money for The Outward Bound Trust, an educational charity. Accompanied by a group, he will abseil down 1,056 feet of the tallest building in Europe: The highest ever attempted descent by a civilian.
Mahjoor’s goal is to raise a minimum of £150,000/€190,000 of which he has personally donated the initial £20,000/€25,000.Led by the Chairman of The Outward Bound Trust, His Royal Highness The Duke of York, Prince Andrew, the charity has enabled over one million underprivileged youths to participate in outdoor programmes, providing important lessons in responsibility, teamwork and leadership.
Mahjoor commented: “Some may think I’ve gone a bit mad to undertake this challenge. But being that it’s for such a wonderful cause that I so very much believe in, I couldn’t possibly turn down the opportunity. To raise money to ensure that this programme continues to impact the lives of many more young people for years to come is simply a privilege.”
This story originally appeared in The Column. Click here to view that issue.
Influence of Concentration in Conventional GPC/SEC and Advanced Detection GPC/SEC
March 21st 2025Sample concentration is a parameter that can influence the quality of gel permeation chromatography/size-exclusion chromatography (GPC/SEC) separations and the obtained results. Understanding this influence can help to support the development of reliable GPC/SEC methods.
Multi-Step Preparative LC–MS Workflow for Peptide Purification
March 21st 2025This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid chromatography–mass spectrometry (LC–MS). The process involves optimizing separation conditions, scaling-up, fractionating, and confirming purity and recovery, using a single LC–MS system. High purity and recovery rates for synthetic peptides such as parathormone (PTH) are achieved. The method allows efficient purification and accurate confirmation of peptide synthesis and is suitable for handling complex preparative purification tasks.
